Impairment of absorption of digoxin by acarbose

Journal of Clinical Pharmacology

Volumn 38, Issue 7, 1998, Pages 654-657

  Miura, Takanori ^a   Ueno, Kazuyuki ^b   Tanaka, Kazuhiko ^c   Sugiura, Youji ^a   Mizutani, Masaru ^a   Takatsu, Fumimaro ^a   Takano, Yumiko ^d   Shibakawa, Masahiko ^b  

^a Chita Kousei Hospital   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^c HYOGO COLLEGE OF MEDICINE   (Japan)

^d Chiron KK   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; DIGOXIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIGOXIN BLOOD LEVEL; DRUG ABSORPTION; DRUG ANTAGONISM; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRANSIT; HUMAN; HUMAN EXPERIMENT; MALE; RANDOMIZED CONTROLLED TRIAL;

EID: 0031902258     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1552-4604.1998.tb04474.x     Document Type: Article

References (14)

1. Dimitriadis G, Raptis S: Alpha-glucosidase inhibition in the treatment of diabetes mellitus. Horm Metab Res 1992;26(Suppl): 42-49.
2. Buchanan DR, Collier A, Rodrigues E, Millar AM, Gray RS, Clarke BF: Effectiveness of acarbose, an alpha-glucosidase inhibitor, in uncontrolled non-obese non-insulin dependent diabetes. Ear J Clin Pharmacol 1988;34:51-53.
3. Brown DD, Juhl RP: Decreased bioavailability of digoxin due to antacids and kaolin-pectin. N Engl J Med 1976;295:1034-1037.
4. Aronson JK: Clincal pharmacokinetics of digoxin. Clin Pharmacokinet 1980;5:137-149.
5. Doering W: Quinidine-digoxin interaction: pharmacokinetics, underlying mechanism and clinical implications. N Engl J Med 1979;301:400-404.
6. Harger WD, Fenster P, Mayersohn M, Perrier D, Graves P, Marcus FI, et al: Digoxin-quinidine interaction: pharmacokinetic evaluation. N Engl J Med 1979;300:1238-1241.
7. Klein HO, Lang R, Weiss E, Segni ED, Libhaber C, Guerrero J, et al: The influence of verapamil on serum digoxin concentration. Circulation 1982;65:998-1003.
8. Pederson KE, Dorph-Pederson A, Hvidt S, Klitgard NA, Pederson KK: The long term effect of verapamil on plasma digoxin concentration and renal digoxin clearance in healthy subjects. Eur J Clin Pharmacol 1982;22:123-127.
9. Manninen V, Apajalahti A, Melin J, Karesija M: Altered absorption of digoxin in patients given propantheline and metoclopramide. Lancet 1973;1:398-399.
10. Mativier B, Servin A, Renault H, Jacquot C: Pharmacokinetic study of digoxin-benzamide interaction in rat. Int J Nucl Med Biol 1984;11:103-105.
11. Serrano JS, Jimenez CM, Serrano MI, Balboa B: A possible interaction of potential clinical interest between digoxin and acarbose. Clin Pharmacol Ther 1996;60:589-592.
12. Miller JJ, Strab RW, Valdes R: Analytical performance of a monoclonal digoxin assay with increased specificity on the ACS: 180. Ther Drug Monitor 1996;18:65-72.
13. Ochs H, Boden G, Schafer PK: Absorption of digoxin from the distal parts of the intestine in man. Eur J Clin Pharmacol 1975;9: 95-97.
14. Caldwell JH, Cline CT: Biliary excretion of digoxin in man. Clin Pharmacol Ther 1976;19:410-415.